Rocket Doctor AI joins the B2i Digital Featured Company Program and its Network of more than 1.7 million Retail and Institutional Market Participants

VANCOUVER, British Columbia, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”) has entered into a digital advisory agreement (the “Agreement”) to retain B2i Digital, Inc. ("B2i Digital"), a New York corporation, to provide digital marketing advisory services, subject to the approval of the Canadian Securities Exchange (the "Exchange").

B2i Digital will provide investor-focused digital marketing advisory services, including building and maintaining a featured company profile on b2idigital.com, creating and managing paid digital advertising campaigns, developing investor-focused content and creative materials, distributing content across social media channels, conducting email marketing campaigns to the investing community, and connecting the Company with relevant investor conferences and speaking opportunities.

"We are excited to be featured in B2i Digital’s program. This collaboration is a pivotal element of our strategic initiative to broaden our presence across the US, including New York, ensuring our physician-built, AI-powered solutions reach those who need them most," said Dr. Essam Hamza, CEO of Rocket Doctor AI.

The promotional activity will be conducted across the following platforms and mediums: